MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, RGBP has $237,076 in assets. $6,810,073 in debts. $4,578 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
3.48%
Cash Ratio
0.07%
Debt to Asset Ratio
2872.53%
Assets Breakdown
    • Accounts receivable, related par...
    • Cash
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Retained earnings (deficit)
    • Additional paid in capital
    • Derivative liability
    • Others

Unit: Dollar
Balance Sheets
2025-12-31
2025-09-30
2025-06-30
Cash
4,578 69,555 -
Accounts receivable, related party-Related Party
232,298 204,873 -
Prepaid expenses
200 200 200
Cash
--1,761
Accounts receivable, related party
--177,147
Total current assets
237,076 274,628 179,108
Investment securities, related party
--17,733
Total assets
237,076 274,628 196,841
Accounts payable
11,024 1,714 30,477
Accrued expenses
1,852,221 1,838,230 1,774,158
Notes payable-Nonrelated Party
--0
Notes payable-Related Party
132,504 191,339 266,339
Unearned income
1,306,971 1,338,611 1,370,251
Derivative liability
2,460,443 2,079,618 1,780,402
Convertible notes payable, net of unamortized debt discount
947,132 1,006,521 769,905
Other current liabilities
99,776 99,776 21,000
Preferred stock, value-Series AAPreferred Stock
--0
Total current liabilities
6,810,073 6,555,811 6,012,532
Preferred stock, value
--0
Total liabilities
6,810,073 6,555,811 6,012,532
Common stock (.0001 par value) 5,800,000,000 authorized and 108,054,704 and 39,374,704 shares issued and outstanding, respectively
10,806 3,939 3,157
Preferred stock, value-Series APreferred Stock
1,011 1,011 1,011
Preferred stock, value-Series MPreferred Stock
3 3 3
Preferred stock, value-Series NCPreferred Stock
2 2 2
Additional paid in capital
16,297,234 15,628,062 15,504,134
Other comprehensive income
-222,580 -222,580 -204,847
Retained earnings (deficit)
-22,659,473 -21,691,620 -21,119,151
Total stockholders equity (deficit)
-6,572,997 -6,281,183 -5,815,691
Total liabilities & stockholders equity (deficit)
237,076 274,628 196,841
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses$200 Accounts receivable,related party-Related...$232,298 Cash$4,578 Total current assets$237,076 Total assets$237,076 Retained earnings(deficit)-$22,659,473 Other comprehensiveincome-$222,580 Total liabilities &stockholders equity...$237,076 Total stockholdersequity (deficit)-$6,572,997 Additional paid in capital$16,297,234 Preferred stock,value-Series NCPreferred...$2 Preferred stock,value-Series MPreferred...$3 Preferred stock,value-Series APreferred...$1,011 Common stock (.0001 parvalue) 5,800,000,000...$10,806 Total liabilities$6,810,073 Total currentliabilities$6,810,073 Other currentliabilities$99,776 Convertible notes payable,net of unamortized...$947,132 Derivative liability$2,460,443 Unearned income$1,306,971 Notespayable-Related Party$132,504 Accrued expenses$1,852,221 Accounts payable$11,024

Regen BioPharma Inc (RGBP)

Regen BioPharma Inc (RGBP)